NCT04888312 2025-10-08
OPTIMIZE-1
Alligator Bioscience AB
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT06758544 2025-08-17
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Guangdong Provincial People's Hospital
Phase 1/2 Recruiting
NCT06844422 2025-02-25
Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
Shandong Cancer Hospital and Institute
Phase 1/2 Recruiting
NCT00041808 2005-06-24
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
FeRx
Phase 1/2 Completed